{"filing":{"accession_number":"0001079973-26-000721","cik":"0001799191","ticker":"TOIIW","company_name":"Oncology Institute, Inc.","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"toi_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000721/toi_8k.htm"},"events":[{"id":10466,"run_id":9176,"accession_number":"0001079973-26-000721","anchor_item_number":"1.05","event_type":"cybersecurity_incident","event_domain":"legal","is_material":true,"confidence":0.95,"summary":"The filing explicitly discloses a material cybersecurity incident under Item 1.05, involving unauthorized access to the Company's information systems affecting patient data. Kroll notified the Company on May 20, 2026 that the Vendor detected unauthorized third-party access to systems containing patient information. Although the Company states the incident has not yet had a material operational impact, the disclosure of patient data compromise, potential regulatory and legal risks, and the need for credit monitoring services constitute a material cybersecurity incident requiring disclosure under the 2023 cybersecurity rules.","company_name":"Oncology Institute, Inc.","ticker":"TOIIW","filing_date":"2026-05-22","submitted_at":null,"items":[{"id":6783,"accession_number":"0001079973-26-000721","item_number":"1.05","item_title":"Material Cybersecurity Incidents.","event_type":"cybersecurity_incident","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"The filing explicitly discloses a material cybersecurity incident under Item 1.05, involving unauthorized access to the Company's information systems affecting patient data. Kroll notified the Company on May 20, 2026 that the Vendor detected unauthorized third-party access to systems containing patient information. Although the Company states the incident has not yet had a material operational impact, the disclosure of patient data compromise, potential regulatory and legal risks, and the need for credit monitoring services constitute a material cybersecurity incident requiring disclosure under the 2023 cybersecurity rules.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:22:33.774073+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6783,"accession_number":"0001079973-26-000721","item_number":"1.05","item_title":"Material Cybersecurity Incidents.","event_type":"cybersecurity_incident","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"The filing explicitly discloses a material cybersecurity incident under Item 1.05, involving unauthorized access to the Company's information systems affecting patient data. Kroll notified the Company on May 20, 2026 that the Vendor detected unauthorized third-party access to systems containing patient information. Although the Company states the incident has not yet had a material operational impact, the disclosure of patient data compromise, potential regulatory and legal risks, and the need for credit monitoring services constitute a material cybersecurity incident requiring disclosure under the 2023 cybersecurity rules.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:22:33.774073+00:00","company_name":"Oncology Institute, Inc.","ticker":"TOIIW","filing_date":"2026-05-22"}]}